Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke

By Ly John V   Zavala Jorge A   Donnan Geoffrey A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1571-1581

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke: Scientific Rationale and Available Evidence

By Arthur M. Pancioli  

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 981-988

Adis International

Access to resources Recommend Favorite

National Use of Thrombolysis with Alteplase for Acute Ischaemic Stroke via Telemedicine in Denmark: A Model of Budgetary Impact and Cost Effectiveness

By Ehlers Lars  

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 73-81

Adis International

Access to resources Recommend Favorite

Neuroprotection for Ischaemic Stroke: An Unattainable Goal?

By Liebeskind D.S.   Kasner S.E.  

CNS Drugs, Vol. 15, Iss. 3, 2001-01 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions

By  

Current Neuropharmacology, Vol. 2, Iss. 3, 2004-07 ,pp. : 265-276

Bentham Science Publishers

Access to resources Recommend Favorite